| 臺大學術典藏 |
2021-03-11T08:34:31Z |
Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells
|
Jen-Chang Ko;Ciou S.-C.;Cheng C.-M.;Wang L.-H.;Hong J.-H.;Jheng M.-Y.;Ling S.-T.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:34:31Z |
The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer
|
Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:34:30Z |
The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells
|
Jen-Chang Ko;Wang L.-H.;Jhan J.-Y.;Ciou S.-C.;Hong J.-H.;Lin S.-T.;Lin Y.-W.; JEN-CHANG KO; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:34:30Z |
Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells
|
Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Cheng C.-M.;Ciou S.-C.;Lin S.-T.;Jheng M.-Y.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:43Z |
Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells
|
Jen-Chang Ko;Ciou S.-C.;Cheng C.-M.;Wang L.-H.;Hong J.-H.;Jheng M.-Y.;Ling S.-T.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:43Z |
The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer
|
Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:42Z |
The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells
|
JEN-CHANG KO; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:42Z |
Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells
|
Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Cheng C.-M.;Ciou S.-C.;Lin S.-T.;Jheng M.-Y.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:38Z |
The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer
|
Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:37Z |
The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells
|
JEN-CHANG KO; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:37Z |
Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells
|
JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:37Z |
Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells
|
Jen-Chang Ko;Ciou S.-C.;Cheng C.-M.;Wang L.-H.;Hong J.-H.;Jheng M.-Y.;Ling S.-T.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Cheng C.-M.; Wang L.-H.; Hong J.-H.; Jheng M.-Y.; Ling S.-T.; Lin Y.-W. |
| 臺大學術典藏 |
2021-02-26T02:00:26Z |
Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit
|
Wang S.H.;Wang-Huei Sheng;Chang Y.Y.;Wang L.H.;Lin H.C.;Chen M.L.;Pan H.J.;Ko W.J.;Chang S.C.;Lin F.Y.; Wang S.H.; WANG-HUEI SHENG; Chang Y.Y.; Wang L.H.; Lin H.C.; Chen M.L.; Pan H.J.; Ko W.J.; Chang S.C.; Lin F.Y. |
| 臺大學術典藏 |
2021-02-26T02:00:07Z |
A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii
|
Wang-Huei Sheng;Liao C.-H.;Lauderdale T.-L.;Ko W.-C.;Chen Y.-S.;Liu J.-W.;Lau Y.-J.;Wang L.-H.;Liu K.-S.;Tsai T.-Y.;Lin S.-Y.;Hsu M.-S.;Hsu L.-Y.;Chang S.-C.; WANG-HUEI SHENG; Liao C.-H.; Lauderdale T.-L.; Ko W.-C.; Chen Y.-S.; Liu J.-W.; Lau Y.-J.; Wang L.-H.; Liu K.-S.; Tsai T.-Y.; Lin S.-Y.; Hsu M.-S.; Hsu L.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2021-01-29T03:17:22Z |
Increased risk of pneumonia in patients receiving gonadotropin-releasing hormone agonists for prostate cancer
|
Chung S.-D.;Shih-Ping Liu;Lin H.-C.;Wang L.-H.; Chung S.-D.; SHIH-PING LIU; Lin H.-C.; Wang L.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:59Z |
Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma
|
Cheng A.-L.; KUN-HUEI YEH; Fine R.L.; Chuang S.-E.; Yang C.-H.; Wang L.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-01-06T08:24:03Z |
The changes of mite-specific immunoglobulin A and transforming growth factor-β1 during immunotherapy of children with dust mite allergy
|
YAO-HSU YANG; Tsai M.-J.; Chiang B.-L.; Wang L.-H.;Yao-Hsu Yang;Tsai M.-J.;Chiang B.-L.; Wang L.-H. |
| 臺大學術典藏 |
2021-01-06T05:50:58Z |
Eradicating acute hemolysis following transcatheter closure of ductus arteriosus by immediate deployment of a second device
|
Wang L.-H.; JOU-KOU WANG; Mullins C.E. |
| 臺大學術典藏 |
2021-01-06T03:59:04Z |
Involvement of two Sp1 elements in basal endothelial prostaglandin H synthase-1 promoter activity
|
Xu X.-M.; JIH-LUH TANG; Chen X.; Wang L.-H.; Wu K.K.-Y. |
| 國立成功大學 |
2021 |
How Should i Do? Users' Attitude Toward Information Security and Data Protection Using Smartphone
|
Wang, L.H.;Liou, S. |
| 國立成功大學 |
2021 |
Drs. Wang and Shieh reply
|
Wang, L.-H.;Shieh, C.-C. |
| 臺大學術典藏 |
2020-12-30T02:44:02Z |
Control of vancomycin-resistant enterococci in a hospital: A five-year experience in a Taiwanese teaching hospital
|
Tseng M.-S.; Chien S.-F.; Wang S.-H.; Lin H.-C.; Wang L.-H.; Sun C.-C.; Wang J.-T.;Chen Y.-C.;Shan-Chwen Chang;Chen M.-L.;Pan H.-J.;Chang Y.-Y.;Sun C.-C.;Wang L.-H.;Wang S.-H.;Lin H.-C.;Chien S.-F.;Tseng M.-S.; Wang J.-T.; Chen Y.-C.; SHAN-CHWEN CHANG; Chen M.-L.; Pan H.-J.; Chang Y.-Y. |
| 臺大學術典藏 |
2020-12-30T02:44:02Z |
Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit
|
Sheng W.H.; Wang S.H.; Wang S.H.;Sheng W.H.;Chang Y.Y.;Wang L.H.;Lin H.C.;Chen M.L.;Pan H.J.;Ko W.J.;Shan-Chwen Chang;Lin F.Y.; Chang Y.Y.; Wang L.H.; Lin H.C.; Chen M.L.; Pan H.J.; Ko W.J.; SHAN-CHWEN CHANG; Lin F.Y. |
| 臺大學術典藏 |
2020-12-30T02:43:40Z |
A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii
|
SHAN-CHWEN CHANG; Hsu M.-S.; Hsu L.-Y.; Lin S.-Y.; Tsai T.-Y.; Liu K.-S.; Wang L.-H.; Lau Y.-J.; Sheng W.-H.; Liao C.-H.; Lauderdale T.-L.; Ko W.-C.; Chen Y.-S.; Liu J.-W. |
| 臺大學術典藏 |
2020-12-30T02:43:27Z |
Infection Control and SARS Transmission among Healthcare Workers, Taiwan
|
Lee Y.-T.; Chen D.-S.; Yang P.-C.; Wang L.-H.; Wang S.-H.; SHAN-CHWEN CHANG; Kao C.-L.; Chen P.-J.; Chen Y.-C.; Chen Y.-C.;Chen P.-J.;Shan-Chwen Chang;Kao C.-L.;Wang S.-H.;Wang L.-H.;Yang P.-C.;Chen D.-S.;Lee Y.-T.;Teng C.-M.;Ho H.-N.;Chang M.-F.;Wang J.-T.;Kao C.-L.;Wang W.-K.;Hsiao C.-H.;Hsueh P.-R.; Teng C.-M.; Ho H.-N.; Chang M.-F.; Wang J.-T.; Kao C.-L.; Wang W.-K.; Hsiao C.-H.; Hsueh P.-R. |
